Two-step ovarian cancer immunotherapy made from patients’ own tumor benefits three quarters of trial patients

As many as three quarters of advanced ovarian cancer patients appeared to respond to a new two-step immunotherapy approach — including one patient who achieved complete remission — according to new research.